Evidence map›Paper›PMID 41924351›Full record

ArticleFrontiers in molecular biosciences2026

Expanding the genetic code: phage-driven evolution of pyrrolysyl-synthetase for site-specific incorporation of synthetic phenylalanine and tyrosine derivatives.

Anastasia Dakhnevich, Sabina Miasoutova, Danila Iliushin, Aleksey Rozanov, Roman Ivanov

Abstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anastasia DakhnevichBiotechnology Department, Sirius University of Science and Technology, Sirius, Russia.
Sabina MiasoutovaBiotechnology Department, Sirius University of Science and Technology, Sirius, Russia.
Danila IliushinBiotechnology Department, Sirius University of Science and Technology, Sirius, Russia.
Aleksey RozanovScientific Center of Genetics and Life Sciences, Sirius University of Science and Technology, Sirius, Russia.
Roman IvanovBiotechnology Department, Sirius University of Science and Technology, Sirius, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Pyrrolysyl-tRNA synthetase (PylRS) is a key enzyme for the site-specific incorporation of non-canonical amino acids (ncAAs) into proteins. However, its native form has a limited substrate scope. This study aimed to evolve PylRS from Methods: We used phage-assisted non-continuous evolution (PANCE) to generate a library of PylRS variants under selective pressure for the target ncAAs. Evolved variants were sequenced to identify mutations. Their aminoacylation efficiency and specificity were quantitatively assessed using fluorescence-based incorporation assays and mass spectrometry. Results: Sequencing revealed a polymorphic population of mutations, with a significant cluster located within the enzyme's amino acid binding pocket. Several evolved variants showed an orders-of-magnitude increase in the efficiency of incorporating their target ncAAs compared to the wild-type enzyme. Discussion/Conclusion: Our findings confirm that PANCE is a highly effective method for engineering PylRS variants with strong and specific activity towards desired non-canonical amino acids. The identified mutations, particularly those in the binding pocket, provide a basis for understanding and further optimising substrate specificity in synthetic biology applications.

Indexed as

directed evolutionnoncanonical amino acidPANCEPylRSpyrrolysyl-tRNA synthetasetRNA

Identifiers

PMID41924351
PMCPMC13035772

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.